Drugs News and Research

RSS

At the 30 year mark, AIDS epidemic still poses challenges

Thirty years after America started battling HIV/AIDS, deaths linked to the virus have plummeted. New HIV cases are down by three-quarters. Life expectancy has more than tripled. Many HIV-positive people lead active lives, often on a single pill a day. But there's a darker side: More than 1.2 million Americans still are living with HIV/AIDS, and 40,000 new infections and 16,000 deaths are expected this year.

1 Jun 2011

New York Times examines 30 years of AIDS

The New York Times looks at the evolution of the battle against AIDS since the first federal announcement of the disease 30 years ago this week. "The epidemic has brought a new focus on the power of epidemiology to identify a disease's transmission patterns long before discovery of its cause.

1 Jun 2011

Women with ovarian cancer could benefit from new targeted testing

Women with ovarian cancer could be helped by a new test that identifies the specific type of tumour they have, a conference will hear this week.

1 Jun 2011

POWER study examines impact of HIV infection on Ontario women

Despite significant clinical advances in HIV care, an estimated 25 per cent of new HIV infections in Ontario from 2006 to 2008 were among women, according to a health study by researchers from the Institute for Clinical Evaluative Sciences and St. Michael's Hospital.

1 Jun 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.

1 Jun 2011

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis.

1 Jun 2011

Type II diabetes drug may slow or stop breast cancer tumor metastasis

A protein activated by certain drugs already approved for treating Type II diabetes may slow or stop the spread of breast tumors.

1 Jun 2011

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

McMaster University researchers have discovered a new drug target that may be effective at preventing the onset of Huntington's disease, working much the same way heart medications slow the progression of heart disease and reduce heart attacks.

1 Jun 2011

State roundup: Texas budget cuts; Florida's 'F' in kids' teeth; new insurance programs for Conn., Maine

Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.

1 Jun 2011

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Ampio Pharmaceuticals, Inc. announced today that it received ethics board approval for a Phase 1B clinical trial in Australia of its biologic anti-inflammatory agent, Ampion.

1 Jun 2011

Birth control pill safety issues raised

The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.

1 Jun 2011

Chronic fatigue syndrome and mouse virus – no association

An earlier study published in 2009 had claimed that a mouse virus was the cause of chronic fatigue syndrome. New evidence suggests that this assumption is wrong. According to latest evidence the earlier study findings were likely based on contaminated lab samples, US researchers said Tuesday.

1 Jun 2011

Health IT roundup: Feds monitor privacy breaches and propose changes to HIPPA records sharing

Federal health officials call it the Wall of Shame. It's a government Web page that lists nearly 300 hospitals, doctors and insurance companies that have reported significant breaches of medical privacy in the last couple of years. Such lapses, frightening to consumers, could impede the Obama administration's effort to shift the nation to electronic health care records.

31 May 2011

Almac's main research projects on ovarian, breast cancer to be presented at ASCO 2011

Two of Almac's main research projects have been selected for presentation at the 2011 ASCO meeting. Both of these studies are based on Almac's approach of profiling large clinical datasets and analysing the data for molecular subgroups that can aid in improved diagnosis of cancer by identifying molecular subtypes and by identifying molecular subgroups which are of clinical and therapeutic relevance.

31 May 2011

Scientists study key malaria protein structure to demonstrate how cells grow and move

Researchers from the Walter and Eliza Hall Institute have overturned conventional wisdom on how cell movement across all species is controlled, solving the structure of a protein that cuts power to the cell 'motor'. The protein could be a potential drug target for future malaria and anti-cancer treatments.

31 May 2011

Annual meeting of Society for Prevention Research to be held in Washington, DC

The mass shooting in Tucson that left six people dead and many more injured, including Congresswoman Gabrielle Giffords, brought significant attention to availability, accessibility and quality of treatment services for serious mental, emotional and behavioral disorders and substance abuse.

31 May 2011

Drugs News and Research

At the 30 year mark, AIDS epidemic still poses challenges

New York Times examines 30 years of AIDS

Women with ovarian cancer could benefit from new targeted testing

POWER study examines impact of HIV infection on Ontario women

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

Type II diabetes drug may slow or stop breast cancer tumor metastasis

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

State roundup: Texas budget cuts; Florida's 'F' in kids' teeth; new insurance programs for Conn., Maine

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Birth control pill safety issues raised

Chronic fatigue syndrome and mouse virus – no association

Health IT roundup: Feds monitor privacy breaches and propose changes to HIPPA records sharing

Almac's main research projects on ovarian, breast cancer to be presented at ASCO 2011

Scientists study key malaria protein structure to demonstrate how cells grow and move

Annual meeting of Society for Prevention Research to be held in Washington, DC

Improvements to Medicare prescription drug program benefit MS patients in the 'donut hole'

Study suggests new therapeutic targets for virally-induced asthma attacks

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

New imaging method using fluorescent nanotubes can peer clearly into living mouse's innards

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News